Current Report Filing (8-k)
April 03 2017 - 3:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_________________
Date of Report (Date of earliest event reported):
March 31, 2017
NanoVibronix, Inc.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-36445
|
|
01-0801232
|
(State or other
jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
|
|
9 Derech
Hashalom Street
Nesher, Israel
|
|
36651
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code: (914) 233-3004
525 Executive Boulevard
Elmsford, New York 10523
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4
(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Item 5.02.
|
Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On March 31, 2017, Ira Greenstein submitted his resignation
as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.
Mr. Greenstein’s resignation was not in connection with any disagreement with the Company on any matter relating to the Company’s
operations, policies or practices, or any other matter.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
NanoVibronix, Inc.
|
|
|
|
|
|
|
|
|
|
Date: April 3, 2017
|
By:
|
/s/ Stephen Brown
|
|
|
|
Name: Stephen Brown
|
|
|
|
Title: Chief Financial Officer
|
|
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jun 2024 to Jul 2024
NanoVibronix (NASDAQ:NAOV)
Historical Stock Chart
From Jul 2023 to Jul 2024